José Luis Montesinos
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
José Luis Montesinos has a total of 113 co-authors. Here are the top co-authors by number of shared publications:
- Francisco Valero
Universitat Autónoma de Barcelona
37 shared publications - Xavier Garcia-Ortega
Department of Chemical, Biological and Environmental Engineering, Engineering School, Universitat Autònoma de Barcelona
13 shared publications - Javier Lafuente
GENOCOV Research Group, Department of Chemical, Biological and Environmental Engineering, Escola d'Enginyeria, Universitat Autònoma de Barcelona, 08193 Bellaterra, Spain
8 shared publications - Pau Ferrer
Department of Chemical, Biological and Environmental Engineering, Universitat Autònoma de Barcelona, Catalonia, Spain
8 shared publications Anna Surribas
5 shared publicationsC. Solà
Departament d'Enginyeria Quı́mica, Facultat de Ciències, Universitat Autònoma de Barcelona, 08193 Bellaterra, Barcelona, Spain
5 shared publications
Latest Publications
- Open Access
- 12 October 2026
- Published by Springer Nature in Microbial Cell Factories
How oxygen-limitation shapes the efficiency of key promoters for recombinant protein production in Komagataella phaffii
- 12 October 2026
- Published by Springer Nature in Microbial Cell Factories
Open AccessHow oxygen-limitation shapes the efficiency of key promoters for recombinant protein production in Komagataella phaffii
- Open Access
- 15 April 2026
- Published by Elsevier in Chemical Engineering Journal Advances
- Vol. 26
Bioprocess intensification for 3-hydroxypropionic acid production from methanol using engineered Komagataella phaffii
- 15 April 2026
- Published by Elsevier in Chemical Engineering Journal Advances
- Vol. 26
Open AccessBioprocess intensification for 3-hydroxypropionic acid production from methanol using engineered Komagataella phaffii
- Open Access
- 6 February 2026
- Published by Elsevier in SSRN Electronic Journal
Bioprocess intensification for 3-hydroxypropionic acid production from methanol using engineered Komagataella phaffii
Green methanol is increasingly recognized as an attractive feedstock to produce value-added biochemicals. It can be produced in a renewable manner, e.g., by direct electrochemical reduction of CO2, offering a viable alternative to fossil resources. Thus, it provides a unique opportunity to positively impact sustainability.,The methylotrophic yeast Komagataella phaffii has been recently engineered for 3-hydroxypropionic acid (3-HP) production from methanol. 3-HP is a key building block that can be converted to acrylic acid and other chemicals of interest such as 1,3-propanediol, as well as to biopolymers. However, challenges remain in developing fermentation processes allowing for techno-economically viable and environmentally sustainable bioprocesses.,In this study, different fed-batch operational strategies and conditions, using K. phaffii strain engineered with the synthetic -alanine pathway to produce 3-HP, based on a preprogrammed exponential feeding of methanol to attain a constant specific growth rate or a closed-loop feedback control of methanol concentration were implemented and compared. The latter strategy resulted in better overall process performance, reaching a 3-HP concentration of 42.7 g3-HP/L in the supernatant, a yield on methanol of 0.106 g3-HP/gS and a volumetric productivity of 0.495 g3-HP/(L·h). Additionally, the use of formate as an electron donor in methanol fed-batch cultures were investigated, demonstrating improved process efficiency (final product concentration, yield on methanol and volumetric productivity increase of about 15%),Overall, the results obtained in this study highlight the potential of K. phaffii as a methanol-based platform microbial cell factory, paving the way for further bioprocess intensification for sustainable chemicals production from CO2-derived feedstocks.
- 6 February 2026
- Published by Elsevier in SSRN Electronic Journal
Open AccessBioprocess intensification for 3-hydroxypropionic acid production from methanol using engineered Komagataella phaffii
Green methanol is increasingly recognized as an attractive feedstock to produce value-added biochemicals. It can be produced in a renewable manner, e.g., by direct electrochemical reduction of CO2, offering a viable alternative to fossil resources. Thus, it provides a unique opportunity to positively impact sustainability.,The methylotrophic yeast Komagataella phaffii has been recently engineered for 3-hydroxypropionic acid (3-HP) production from methanol. 3-HP is a key building block that can be converted to acrylic acid and other chemicals of interest such as 1,3-propanediol, as well as to biopolymers. However, challenges remain in developing fermentation processes allowing for techno-economically viable and environmentally sustainable bioprocesses.,In this study, different fed-batch operational strategies and conditions, using K. phaffii strain engineered with the synthetic -alanine pathway to produce 3-HP, based on a preprogrammed exponential feeding of methanol to attain a constant specific growth rate or a closed-loop feedback control of methanol concentration were implemented and compared. The latter strategy resulted in better overall process performance, reaching a 3-HP concentration of 42.7 g3-HP/L in the supernatant, a yield on methanol of 0.106 g3-HP/gS and a volumetric productivity of 0.495 g3-HP/(L·h). Additionally, the use of formate as an electron donor in methanol fed-batch cultures were investigated, demonstrating improved process efficiency (final product concentration, yield on methanol and volumetric productivity increase of about 15%),Overall, the results obtained in this study highlight the potential of K. phaffii as a methanol-based platform microbial cell factory, paving the way for further bioprocess intensification for sustainable chemicals production from CO2-derived feedstocks.
- 1 October 2025
- Published by Springer Nature
- Vol. 2697, 171-176
Determination of Biomass Elemental Composition of Pichia pastoris
A quantitative determination of a consistent biomass elemental composition is required for a wide range of applications, including metabolic engineering, bioprocess parameter calculation, and medium optimization, among others. Its determination relies on the use of different analytical techniques for the range of biochemical compounds considered. In this chapter, a robust methodology is proposed for its determination of yeast, specifically Komagataella phaffii (previously named Pichia pastoris).
- 1 October 2025
- Published by Springer Nature
- Vol. 2697, 171-176
Determination of Biomass Elemental Composition of Pichia pastoris
A quantitative determination of a consistent biomass elemental composition is required for a wide range of applications, including metabolic engineering, bioprocess parameter calculation, and medium optimization, among others. Its determination relies on the use of different analytical techniques for the range of biochemical compounds considered. In this chapter, a robust methodology is proposed for its determination of yeast, specifically Komagataella phaffii (previously named Pichia pastoris).
- Open Access
- 20 February 2024
- Published by Wiley in Microbial Biotechnology
- Vol. 17 (2) , e14411
Synergic kinetic and physiological control to improve the efficiency of Komagataella phaffii recombinant protein production bioprocesses
The yeast Komagataella phaffii ( Pichia pastoris ) is currently considered a versatile and highly efficient host for recombinant protein production ( RPP ). Interestingly, the regulated application of specific stress factors as part of bioprocess engineering strategies has proven potential for increasing the production of recombinant products. This study aims to evaluate the impact of controlled oxygen‐limiting conditions on the performance of K. phaffii bioprocesses for RPP in combination with the specific growth rate ( μ ) in fed‐batch cultivations. In this work, Candida rugosa lipase 1 (Crl1) production, regulated by the constitutive GAP promoter, growing at different nominal μ (0.030, 0.065, 0.100 and 0.120 h −1 ) under both normoxic and hypoxic conditions in carbon‐limiting fed‐batch cultures is analysed. Hypoxic fermentations were controlled at a target respiratory quotient ( RQ ) of 1.4, with excellent performance, using an innovative automated control based on the stirring rate as the manipulated variable developed during this study. The results conclude that oxygen limitation positively affects bioprocess efficiency under all growing conditions compared. The shift from respiratory to respiro‐fermentative metabolism increases bioprocess productivity by up to twofold for the specific growth rates evaluated. Moreover, the specific product generation rate ( q p ) increases linearly with μ , regardless of oxygen availability. Furthermore, this hypoxic boosting effect was also observed in the production of Candida antarctica lipase B (CalB) and pro‐ Rhizopus oryzae lipase (proRol), thus proving the synergic effect of kinetic and physiological stress control. Finally, the Crl1 production scale‐up was conducted successfully, confirming the strategy's scalability and the robustness of the results obtained at the bench‐scale level.
- 20 February 2024
- Published by Wiley in Microbial Biotechnology
- Vol. 17 (2) , e14411
Open AccessSynergic kinetic and physiological control to improve the efficiency of Komagataella phaffii recombinant protein production bioprocesses
The yeast Komagataella phaffii ( Pichia pastoris ) is currently considered a versatile and highly efficient host for recombinant protein production ( RPP ). Interestingly, the regulated application of specific stress factors as part of bioprocess engineering strategies has proven potential for increasing the production of recombinant products. This study aims to evaluate the impact of controlled oxygen‐limiting conditions on the performance of K. phaffii bioprocesses for RPP in combination with the specific growth rate ( μ ) in fed‐batch cultivations. In this work, Candida rugosa lipase 1 (Crl1) production, regulated by the constitutive GAP promoter, growing at different nominal μ (0.030, 0.065, 0.100 and 0.120 h −1 ) under both normoxic and hypoxic conditions in carbon‐limiting fed‐batch cultures is analysed. Hypoxic fermentations were controlled at a target respiratory quotient ( RQ ) of 1.4, with excellent performance, using an innovative automated control based on the stirring rate as the manipulated variable developed during this study. The results conclude that oxygen limitation positively affects bioprocess efficiency under all growing conditions compared. The shift from respiratory to respiro‐fermentative metabolism increases bioprocess productivity by up to twofold for the specific growth rates evaluated. Moreover, the specific product generation rate ( q p ) increases linearly with μ , regardless of oxygen availability. Furthermore, this hypoxic boosting effect was also observed in the production of Candida antarctica lipase B (CalB) and pro‐ Rhizopus oryzae lipase (proRol), thus proving the synergic effect of kinetic and physiological stress control. Finally, the Crl1 production scale‐up was conducted successfully, confirming the strategy's scalability and the robustness of the results obtained at the bench‐scale level.
- Open Access
- 25 June 2020
- Published by Frontiers Media SA in Frontiers in Bioengineering and Biotechnology
- Vol. 8, 632
Continuous Cultivation as a Tool Toward the Rational Bioprocess Development With Pichia Pastoris Cell Factory
The methylotrophic yeast Pichia pastoris (Komagataella phaffii) is currently considered one of the most promising hosts for recombinant protein production (RPP) and metabolites due to the availability of several tools to efficiently regulate the recombinant expression, its ability to perform eukaryotic post-translational modifications and to secrete the product in the extracellular media. The challenge of improving the bioprocess efficiency can be faced from two main approaches: the strain engineering, which includes enhancements in the recombinant expression regulation as well as overcoming potential cell capacity bottlenecks; and the bioprocess engineering, focused on the development of rational-based efficient operational strategies. Understanding the effect of strain and operational improvements in bioprocess efficiency requires to attain a robust knowledge about the metabolic and physiological changes triggered into the cells. For this purpose, a number of studies have revealed chemostat cultures to provide a robust tool for accurate, reliable, and reproducible bioprocess characterization. It should involve the determination of key specific rates, productivities, and yields for different C and N sources, as well as optimizing media formulation and operating conditions. Furthermore, studies along the different levels of systems biology are usually performed also in chemostat cultures. Transcriptomic, proteomic and metabolic flux analysis, using different techniques like differential target gene expression, protein description and 13C-based metabolic flux analysis, are widely described as valued examples in the literature. In this scenario, the main advantage of a continuous operation relies on the quality of the homogeneous samples obtained under steady-state conditions, where both the metabolic and physiological status of the cells remain unaltered in an all-encompassing picture of the cell environment. This contribution aims to provide the state of the art of the different approaches that allow the design of rational strain and bioprocess engineering improvements in Pichia pastoris toward optimizing bioprocesses based on the results obtained in chemostat cultures. Interestingly, continuous cultivation is also currently emerging as an alternative operational mode in industrial biotechnology for implementing continuous process operations.
- 25 June 2020
- Published by Frontiers Media SA in Frontiers in Bioengineering and Biotechnology
- Vol. 8, 632
Open AccessContinuous Cultivation as a Tool Toward the Rational Bioprocess Development With Pichia Pastoris Cell Factory
The methylotrophic yeast Pichia pastoris (Komagataella phaffii) is currently considered one of the most promising hosts for recombinant protein production (RPP) and metabolites due to the availability of several tools to efficiently regulate the recombinant expression, its ability to perform eukaryotic post-translational modifications and to secrete the product in the extracellular media. The challenge of improving the bioprocess efficiency can be faced from two main approaches: the strain engineering, which includes enhancements in the recombinant expression regulation as well as overcoming potential cell capacity bottlenecks; and the bioprocess engineering, focused on the development of rational-based efficient operational strategies. Understanding the effect of strain and operational improvements in bioprocess efficiency requires to attain a robust knowledge about the metabolic and physiological changes triggered into the cells. For this purpose, a number of studies have revealed chemostat cultures to provide a robust tool for accurate, reliable, and reproducible bioprocess characterization. It should involve the determination of key specific rates, productivities, and yields for different C and N sources, as well as optimizing media formulation and operating conditions. Furthermore, studies along the different levels of systems biology are usually performed also in chemostat cultures. Transcriptomic, proteomic and metabolic flux analysis, using different techniques like differential target gene expression, protein description and 13C-based metabolic flux analysis, are widely described as valued examples in the literature. In this scenario, the main advantage of a continuous operation relies on the quality of the homogeneous samples obtained under steady-state conditions, where both the metabolic and physiological status of the cells remain unaltered in an all-encompassing picture of the cell environment. This contribution aims to provide the state of the art of the different approaches that allow the design of rational strain and bioprocess engineering improvements in Pichia pastoris toward optimizing bioprocesses based on the results obtained in chemostat cultures. Interestingly, continuous cultivation is also currently emerging as an alternative operational mode in industrial biotechnology for implementing continuous process operations.
- Open Access
- 1 November 2019
- Published by Springer Nature in Microbial Cell Factories
- Vol. 18 (1) , 1-15
Specific growth rate governs AOX1 gene expression, affecting the production kinetics of Pichia pastoris (Komagataella phaffii) PAOX1-driven recombinant producer strains with different target gene dosage
Background: The PAOX1-based expression system is the most widely used for producing recombinant proteins in the methylotrophic yeast Pichia pastoris (Komagataella phaffii). Despite relevant recent advances in regulation of the methanol utilization (MUT) pathway have been made, the role of specific growth rate (µ) in AOX1 regulation remains unknown, and therefore, its impact on protein production kinetics is still unclear. Results: The influence of heterologous gene dosage, and both, operational mode and strategy, on culture physiological state was studied by cultivating the two PAOX1-driven Candida rugosa lipase 1 (Crl1) producer clones. Specifically, a clone integrating a single expression cassette of CRL1 was compared with one containing three cassettes over broad dilution rate and µ ranges in both chemostat and fed-batch cultivations. Chemostat cultivations allowed to establish the impact of µ on the MUT-related MIT1 pool which leads to a bell-shaped relationship between µ and PAOX1-driven gene expression, influencing directly Crl1 production kinetics. Also, chemostat and fed-batch cultivations exposed the favorable effects of increasing the CRL1 gene dosage (up to 2.4 fold in qp) on Crl1 production with no significant detrimental effects on physiological capabilities. Conclusions: PAOX1-driven gene expression and Crl1 production kinetics in P. pastoris were successfully correlated with µ. In fact, µ governs MUT-related MIT1 amount that triggers PAOX1-driven gene expression—heterologous genes included—, thus directly influencing the production kinetics of recombinant protein.
- 1 November 2019
- Published by Springer Nature in Microbial Cell Factories
- Vol. 18 (1) , 1-15
Open AccessSpecific growth rate governs AOX1 gene expression, affecting the production kinetics of Pichia pastoris (Komagataella phaffii) PAOX1-driven recombinant producer strains with different target gene dosage
Background: The PAOX1-based expression system is the most widely used for producing recombinant proteins in the methylotrophic yeast Pichia pastoris (Komagataella phaffii). Despite relevant recent advances in regulation of the methanol utilization (MUT) pathway have been made, the role of specific growth rate (µ) in AOX1 regulation remains unknown, and therefore, its impact on protein production kinetics is still unclear. Results: The influence of heterologous gene dosage, and both, operational mode and strategy, on culture physiological state was studied by cultivating the two PAOX1-driven Candida rugosa lipase 1 (Crl1) producer clones. Specifically, a clone integrating a single expression cassette of CRL1 was compared with one containing three cassettes over broad dilution rate and µ ranges in both chemostat and fed-batch cultivations. Chemostat cultivations allowed to establish the impact of µ on the MUT-related MIT1 pool which leads to a bell-shaped relationship between µ and PAOX1-driven gene expression, influencing directly Crl1 production kinetics. Also, chemostat and fed-batch cultivations exposed the favorable effects of increasing the CRL1 gene dosage (up to 2.4 fold in qp) on Crl1 production with no significant detrimental effects on physiological capabilities. Conclusions: PAOX1-driven gene expression and Crl1 production kinetics in P. pastoris were successfully correlated with µ. In fact, µ governs MUT-related MIT1 amount that triggers PAOX1-driven gene expression—heterologous genes included—, thus directly influencing the production kinetics of recombinant protein.
- Open Access
- 28 October 2019
- Published by Wiley in Microbial Biotechnology
- Vol. 13 (2) , 315-327
Rationale‐based selection of optimal operating strategies and gene dosage impact on recombinant protein production in Komagataella phaffii ( Pichia pastoris )
Summary: Its features as a microbial and eukaryotic organism have turned Komagataella phaffii ( Pichia pastoris ) into an emerging cell factory for recombinant protein production (RPP). As a key step of the bioprocess development, this work aimed to demonstrate the importance of tailor designing the cultivation strategy according to the production kinetics of the cell factory. For this purpose, K. phaffii clones constitutively expressing ( P GAP ) Candida rugosa lipase 1 (Crl1) with different gene dosage were used as models in continuous and fed‐batch cultures. Production parameters were much greater with a multicopy clone (MCC) than with the single‐copy clone (SCC). Regarding production kinetics, the specific product generation rate (q P ) increased linearly with increasing specific growth rate ( µ ) in SCC; by contrast, q P exhibited saturation in MCC. A transcriptional analysis in chemostat cultures suggested the presence of eventual post‐transcriptional bottlenecks in MCC. After the strain characterization, in order to fulfil overall development of the bioprocess, the performance of both clones was also evaluated in fed‐batch mode. Strikingly, different optimal strategies were determined for both models due to the different production kinetic patterns observed as a trade‐off for product titre, yields and productivity. The combined effect of gene dosage and adequate µ enables rational process development with a view to optimize K. phaffii RPP bioprocesses.
- 28 October 2019
- Published by Wiley in Microbial Biotechnology
- Vol. 13 (2) , 315-327
Open AccessRationale‐based selection of optimal operating strategies and gene dosage impact on recombinant protein production in Komagataella phaffii ( Pichia pastoris )
Summary: Its features as a microbial and eukaryotic organism have turned Komagataella phaffii ( Pichia pastoris ) into an emerging cell factory for recombinant protein production (RPP). As a key step of the bioprocess development, this work aimed to demonstrate the importance of tailor designing the cultivation strategy according to the production kinetics of the cell factory. For this purpose, K. phaffii clones constitutively expressing ( P GAP ) Candida rugosa lipase 1 (Crl1) with different gene dosage were used as models in continuous and fed‐batch cultures. Production parameters were much greater with a multicopy clone (MCC) than with the single‐copy clone (SCC). Regarding production kinetics, the specific product generation rate (q P ) increased linearly with increasing specific growth rate ( µ ) in SCC; by contrast, q P exhibited saturation in MCC. A transcriptional analysis in chemostat cultures suggested the presence of eventual post‐transcriptional bottlenecks in MCC. After the strain characterization, in order to fulfil overall development of the bioprocess, the performance of both clones was also evaluated in fed‐batch mode. Strikingly, different optimal strategies were determined for both models due to the different production kinetic patterns observed as a trade‐off for product titre, yields and productivity. The combined effect of gene dosage and adequate µ enables rational process development with a view to optimize K. phaffii RPP bioprocesses.